Previous 10 | Next 10 |
Heat Biologics (NASDAQ: HTBX ) : Q2 GAAP EPS of -$0.05 beats by $0.03 . Revenue of $0.59M (+73.5% Y/Y) beats by $0.19M . Shares +1.4% PM. Press Release More news on: Heat Biologics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news,
Progress on COVID-19 Vaccine Program Reports over $100 million in cash and short-term investments as of August 6, 2020 DURHAM, NC / ACCESSWIRE / August 7, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-stage biopharmaceutical company focused on developing firs...
Analysts Appear Bullish On These Penny Stocks It has been a big year for penny stocks and analysts are taking notice. In fact, some of the most talked-about names recently – Kodak, Novavax, Workhorse Group, Nio – were all penny stocks earlier this year. Hindsight is 20/20, of c...
White paper highlights potential of Heat's vaccine to boost T cell immunity, alone or in combination with other vaccines DURHAM, NC / ACCESSWIRE / August 5, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in...
Companies at the forefront of coronavirus vaccine research have been a veritable gold mine for investors this year. For example, shares of Moderna (NASDAQ: MRNA) have gained a staggering 278% over the first seven months of 2020, while Novavax 's (NASDAQ: NVAX) stock has posted a healthy 3...
FSD Pharma (NASDAQ: HUGE ) +130% . on decision to surrender health Canada licenses for subsidiary FV Pharma. More news on: FSD Pharma Inc., Kandi Technologies Group, Inc., Edesa Biotech, Inc., Stocks on the move, , Read more ...
Heat Biologics (NASDAQ: HTBX) , a prerevenue biotech, is off to a strong start today. The company's shares spiked by as much as 46% in early-morning trading in response to a positive update for its experimental COVID-19 vaccine. Specifically, Heat announced that its COVID-19 vaccine candidat...
Sonoma Pharmaceuticals (NASDAQ: SNOA ) +82% on potential of disinfectant/sanitizer in airline industry. More news on: Sonoma Pharmaceuticals, Inc., Eastman Kodak Company, Heat Biologics, Inc., Stocks on the move, , Read more ...
Heat Biologics (NASDAQ: HTBX ) announces results from preclinical testing of its COVID-19 vaccine candidate that, it says, showed immunogenicity in animal models including expansion of human-HLA-restricted T cells against immunodominant epitopes of SARS-CoV-2 spike protein, adding that t...
Confirms stimulation of human-HLA-restricted transgenic mouse T-cells against immunodominant epitopes of SARS-CoV-2 Spike protein DURHAM, NC / ACCESSWIRE / July 29, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-stage biopharmaceutical company focused on developing...
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C., July 18, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) , (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced the successful execution of its first...
DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced that the Company’s Board of ...
DURHAM, N.C., June 17, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported that it received notice ...